Former Alnylam Executive Soni Joins Reata Pharmaceuticals as CFO

Reata Pharmaceuticals (NASDAQ: [[ticker:RETA]]) has appointed Manmeet Soni to serve as chief financial officer and executive vice president. With Soni’s hire, James Wilson, CFO and executive vice president of strategy, will shift to a new role as Reata’s executive vice president of operations. Soni stepped down as CFO of Alnylam Pharmaceuticals (NASDAQ: [[ticker:ALNY]]) last month. His experience also includes CFO posts at Ariad Pharmaceuticals and Pharmacyclics. Irving, TX-based Reata is developing drugs that target molecular pathways governing cellular metabolism and inflammation.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan